Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Core Insights - Cosmos Health Inc. has entered into a securities purchase agreement for the issuance of up to $300 million in senior secured convertible promissory notes to support its Ethereum digital asset treasury reserve strategy [1][3] - The financing is seen as a strategic milestone, providing shareholders with direct exposure to Ethereum, which is one of the most widely adopted digital assets [3] - At least 72.5% of the net proceeds from each tranche will be allocated to building the digital asset treasury reserve, with the remainder for working capital and growth initiatives [3] Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada, with a portfolio of proprietary pharmaceutical and nutraceutical brands [5] - The company manufactures pharmaceuticals and food supplements under European Good Manufacturing Practices and distributes a broad line of pharmaceuticals and parapharmaceuticals in Greece and the UK [5] - Cosmos Health has established R&D partnerships targeting major health disorders and has entered the telehealth space through the acquisition of ZipDoctor, Inc. [5] Strategic Initiatives - The company plans to strategically accumulate Ethereum to enhance long-term shareholder value through increasing ETH-per-share [6] - ETH assets will be custodied and staked through institutional infrastructure provided by BitGo Trust Company [6] - The treasury initiative complements ongoing digital transformation and e-commerce efforts, with potential exploration of blockchain use cases in supply chain traceability and global consumer engagement [6]